Comment
doi: 10.1016/S2213-8587(14)70036-1.
Epub 2014 Apr 4.
Basal insulin or longacting GLP-1 receptor agonists-making the right choice
Affiliations
- PMID: 24731676
- DOI: 10.1016/S2213-8587(14)70036-1
Item in Clipboard
Comment
Basal insulin or longacting GLP-1 receptor agonists-making the right choice
Lancet Diabetes Endocrinol.
2014 Jun.
No abstract available
Comment on
-
Exenatide once weekly versus insulin glargine for type 2 diabetes (DURATION-3): 3-year results of an open-label randomised trial.Lancet Diabetes Endocrinol. 2014 Jun;2(6):464-73. doi: 10.1016/S2213-8587(14)70029-4. Epub 2014 Apr 4. Lancet Diabetes Endocrinol. 2014. PMID: 24731672 Clinical Trial.
Similar articles
-
Longacting exenatide in diabetes: DURATION-3.Lancet. 2010 Jun 26;375(9733):2198-9. doi: 10.1016/S0140-6736(10)60836-7. Lancet. 2010. PMID: 20609957 No abstract available.
-
Pharmacotherapy: GLP-1 analogues and insulin: sound the wedding bells?Nat Rev Endocrinol. 2011 Apr;7(4):193-5. doi: 10.1038/nrendo.2011.30. Epub 2011 Feb 22. Nat Rev Endocrinol. 2011. PMID: 21326278 No abstract available.
-
Options for prandial glucose management in type 2 diabetes patients using basal insulin: addition of a short-acting GLP-1 analogue versus progression to basal-bolus therapy.Diabetes Obes Metab. 2014 Mar;16(3):206-14. doi: 10.1111/dom.12136. Epub 2013 Jun 20. Diabetes Obes Metab. 2014. PMID: 23711193 Review.
-
Insulin avoidance and treatment outcomes among patients with a professional driving licence starting glucagon-like peptide 1 (GLP-1) agonists in the Association of British Clinical Diabetologists (ABCD) nationwide exenatide and liraglutide audits.Diabet Med. 2012 May;29(5):690-2. doi: 10.1111/j.1464-5491.2011.03475.x. Diabet Med. 2012. PMID: 21988449 No abstract available.
-
The novel use of GLP-1 analogue and insulin combination in type 2 diabetes mellitus.Recent Pat Endocr Metab Immune Drug Discov. 2012 May;6(2):129-35. doi: 10.2174/187221412800604563. Recent Pat Endocr Metab Immune Drug Discov. 2012. PMID: 22435393 Review.
Cited by
-
Should glucagon-like peptide-1 receptor agonist treatment be withheld in preoperative management?J Diabetes. 2023 Sep;15(9):712-713. doi: 10.1111/1753-0407.13469. J Diabetes. 2023. PMID: 37727016 Free PMC article. No abstract available.
-
An Update on GLP-1 Receptor Agonists.J Diabetes. 2025 Aug;17(8):e70147. doi: 10.1111/1753-0407.70147. J Diabetes. 2025. PMID: 40842408 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
